News
20h
Zacks Investment Research on MSNHere's Why Gilead Sciences (GILD) is a Strong Value StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Ipsen and its fellow French partner Genfit are competing with Intercept and Advanz’s Ocaliva, which was approved in 2016 and ...
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
The Handmaid’s Tale Season 6 finale is just a few weeks away, but fans hoping for a neatly wrapped story to June Osbourne and ...
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...
3d
US Weekly on MSNWhat to Know About ‘The Handmaid’s Tale’ Spinoff ‘The Testaments’: Returning Cast Members and MoreHulu's spinoff of 'The Handmaid's Tale' titled 'The Testaments' comes after the original show's sixth and final season ...
Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...
"It's not about a relationship she chose, like with Fred," Bruce Miller says, explaining why writers chose to introduce the ...
As the final season of "The Handmaid's Tale" begins today, we're taking a look back on everything to know about the hit Hulu ...
4d
Dexerto on MSNWhat is a Martha? The Handmaid’s Tale social rankings explainedWith The Handmaid’s Tale Season 6 airing now, here’s what you need to know about Marthas and the social hierarchy for women ...
Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection ...
Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results